Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr;51(5):1464-1466.
doi: 10.1007/s00259-024-06642-9.

Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance

Levent Kabasakal  1 , Ruştu Turkay  2 , Bulent Onal  3
Affiliations
Editorial

Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance

Levent Kabasakal et al. Eur J Nucl Med Mol Imaging. 2024 Apr.
No abstract available

PubMed Disclaimer

References

    1. Stefanova V, Buckley R, Flax S, Spevack L, Hajek D, Tunis A, Lai E, Loblaw A; Collaborators. Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. Prostate Cancer Detection Rate, Complications and Patient Tolerability. J Urol. 2019;201(6):1121–1126.
    1. Barzell WE, Melamed MR, Cathcart P, Moore CM, Ahmed HU, Emberton M. Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer. J Urol. 2012;188(3):762–7. - DOI - PubMed
    1. Porten SP, Whitson JM, Cowan JE, Perez N, Shinohara K, Carroll PR. Changes in cancer volume in serial biopsies of men on active surveillance for early-stage prostate cancer. J Urol. 2011;186(5):1825–9. - DOI - PubMed
    1. Bokhorst LP, Alberts AR, Rannikko A, Valdagni R, Picles T, Kakehi Y, et al. Compliance rates with the prostate cancer research international active surveillance (PRIAS) protocol and disease reclassification in noncompliers. Eur Urol. 2015;68(5):814–21. - DOI - PubMed
    1. Turkay R, Inci E, Yildiz O, Ozgur E, Taşci AI. Cognitive versus magnetic resonance-ultrasound fusion prostate biopsy: which one is worthier to perform? Ultrasound Q. 2020;36(4):345–9. - DOI - PubMed

Publication types

LinkOut - more resources